3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Motor Activity
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Squamous Intraepithelial Lesions
1
Sezary Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphedema of Face
1
Interventions
Radiotherapy
10
fludarabine phosphate
9
Peripheral Blood Stem Cell Transplantation
8
Cyclosporine
7
Cyclophosphamide
7
Busulfan
7
Whole-Body Irradiation
6
Melphalan
6
Radiofrequency Ablation
5
Mycophenolic Acid
5
Filgrastim
5
Antilymphocyte Serum
5
Surveys and Questionnaires
4
Surgical Procedures, Operative
4
Methotrexate
4
Etoposide
4
Drug Therapy
4
Cisplatin
4
fludarabine
3
Radiosurgery
3
Injections
3
Hepatectomy
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
lenvatinib
2
Vinblastine
2
Videotape Recording
2
Thiotepa
2
Standard of Care
2
Sorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Recurrence
×
Observation
×
Clear all
NCT00975520
2024-11-27
RTN2
Melanoma and Skin Cancer Trials Limited
Phase NA
Completed
50 enrolled